The initiation of coverage by UBS with a Neutral rating suggests that the analyst sees the stock as fairly valued at current levels. The price target of $65 provides a reference point for investors, but does not necessarily suggest a strong upside or downside. Therefore, the short-term impact on the stock price is likely to be neutral.